Browsing by Author "Danjuma NM, Ezenwa J"
Now showing 1 - 1 of 1
Results Per Page
Sort Options
Item Pharmacists’ roles in optimizing pharmaceutical C are for HIV/AIDS patients in University of Maiduguri Teaching Hospital, North-Eastern Nigeria(Published by Department of Pharmacology and Therapeutics, Ahmadu Bello University, Zaria, 2011) Giwa, A; Giwa, HBF; Yakubu, SI; Ajiboye, WT; Abubakar, D; Danjuma NM, Ezenwa JProvision of Pharmaceutical care to patients suffering from chronic diseases such as HIV/AIDS poses great challenges, especially due to use of multiple drug regimen. This study was aimed at examining pharmacists’roles in optimizing pharmaceutical care for HIV/AIDS patients in University of Maiduguri Teaching Hospital, North- Eastern Nigeria in 2010. A cross-sectional study of total population of pharmacists (28) involved in HIV/AIDS management in University of Maiduguri Teaching Hospital was carried out using self administered questionnaire. Majority of pharmacists confirmed that theyidentified,resolved and preventedanti-retroviraldrug therapy problems. Theyprovided HIV/AIDS patients with adequate information necessary for their therapy and were involved in modification of the therapy. Open and effective channels of communicationsexisted between pharmacists and other members of the health care team in HIV/AIDS management. However, Pharmacists were not involved in development of therapeutic plans for HIV/AIDS patients and do not carry out assessment of HIV/AIDS therapy.Home visitations were not carried out by all pharmacists and majority of them do not document ARV therapy as well as the result of each patient managed. Pharmacists’ roles inidentifying,resolving and preventing ARV drug therapy problems, adequate patient counselling, effective communication with other health care providers would optimize pharmaceutical care for HIV/AIDS Patients. These would contribute to attaining goals of pharmaceutical care. Pharmacists should be involved in the development of ARV therapeutic plan, assessment and documentation of ARV therapies and their results to further optimize pharmaceutical care for HIV/AIDS Patients.